136 related articles for article (PubMed ID: 6514017)
1. Saturable uptake of [3H]-tryptamine in rabbit platelets is inhibited by 5-hydroxytryptamine uptake blockers.
Segonzac A; Tateishi T; Langer SZ
Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):33-7. PubMed ID: 6514017
[TBL] [Abstract][Full Text] [Related]
2. Tryptamine, a substrate for the serotonin transporter in human platelets, modifies the dissociation kinetics of [3H]imipramine binding: possible allosteric interaction.
Segonzac A; Raisman R; Tateishi T; Schoemaker H; Hicks PE; Langer SZ
J Neurochem; 1985 Feb; 44(2):349-56. PubMed ID: 3871227
[TBL] [Abstract][Full Text] [Related]
3. Effects of imipramine and some tryptamine derivatives on the efflux of 3H-5-hydroxytryptamine from rabbit platelets.
Wölfel R; Graefe KH
J Neural Transm Suppl; 1991; 34():77-83. PubMed ID: 1817167
[TBL] [Abstract][Full Text] [Related]
4. 5-Methoxytryptoline, a competitive endocoid acting at [3H]imipramine recognition sites in human platelets.
Segonzac A; Schoemaker H; Tateishi T; Langer SZ
J Neurochem; 1985 Jul; 45(1):249-56. PubMed ID: 2987413
[TBL] [Abstract][Full Text] [Related]
5. On the 5-hydroxytryptamine transport across the plasma membrane of rabbit platelets and its inhibition by imipramine.
Wölfel R; Böhm W; Halbrügge T; Bönisch H; Graefe KH
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):1-8. PubMed ID: 3237251
[TBL] [Abstract][Full Text] [Related]
6. [3H]-5-methoxytryptoline is not actively accumulated by rabbit platelets.
Segonzac A; Schoemaker H; Lee CR; Langer SZ
Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):1-4. PubMed ID: 3627287
[TBL] [Abstract][Full Text] [Related]
7. [3H]imipramine binding of protein nature in human platelets: inhibition by 5-hydroxytryptamine and 5-hydroxytryptamine uptake inhibitors.
Marcusson J; Tiger G
J Neurochem; 1988 Apr; 50(4):1032-6. PubMed ID: 3279163
[TBL] [Abstract][Full Text] [Related]
8. Evidence for various tryptamines and related compounds acting as substrates of the platelet 5-hydroxytryptamine transporter.
Wölfel R; Graefe KH
Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):129-36. PubMed ID: 1570019
[TBL] [Abstract][Full Text] [Related]
9. Temperature dependence of drug interaction with the platelet 5-hydroxytryptamine transporter: a clue to the imipramine selectivity paradox.
Segonzac A; Schoemaker H; Langer SZ
J Neurochem; 1987 Feb; 48(2):331-9. PubMed ID: 2947974
[TBL] [Abstract][Full Text] [Related]
10. Platelets and biogenic amines. 2. Indications for a discrete low affinity uptake mechanism shared by norepinephrine and 5-hydroxytryptamine in human platelets.
Malmgren R
Psychopharmacology (Berl); 1986; 90(3):384-9. PubMed ID: 3097728
[TBL] [Abstract][Full Text] [Related]
11. Effects of N-ethylmaleimide on 5-hydroxytryptamine transport and sodium content in rabbit platelets.
Wölfel R; Halbrügge T; Graefe KH
Br J Pharmacol; 1989 Aug; 97(4):1308-14. PubMed ID: 2790384
[TBL] [Abstract][Full Text] [Related]
12. Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues.
Born GV; Juengjaroen K; Michal F
Br J Pharmacol; 1972 Jan; 44(1):117-39. PubMed ID: 5015032
[TBL] [Abstract][Full Text] [Related]
13. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin and dopamine uptake by human blood platelets.
Airaksinen MM; Svensk H; Tuomisto J; Komulainen H
Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):308-13. PubMed ID: 7368950
[TBL] [Abstract][Full Text] [Related]
14. Two affinity states for [3H]imipramine binding to the human platelet 5-hydroxytryptamine carrier: an explanation for the allosteric interaction between 5-hydroxytryptamine and imipramine.
O'Riordan C; Phillips OM; Williams DC
J Neurochem; 1990 Apr; 54(4):1275-80. PubMed ID: 2313287
[TBL] [Abstract][Full Text] [Related]
15. High-affinity binding of [3H]6-nitroquipazine to 5-hydroxytryptamine transporter in human platelets.
Hashimoto K; Goromaru T
Eur J Pharmacol; 1990 Oct; 187(3):295-302. PubMed ID: 2073917
[TBL] [Abstract][Full Text] [Related]
16. Uptake of 5-hydroxytryptamine in blood platelets and its inhibition by drugs: role of plasma membrane and granular storage.
Laubscher A; Pletscher A
J Pharm Pharmacol; 1979 May; 31(5):284-9. PubMed ID: 37296
[TBL] [Abstract][Full Text] [Related]
17. 5-Hydroxytryptamine uptake and release in relation to aggregation of rabbit platelets.
Baumgartner HR
J Physiol; 1969 Apr; 201(2):409-23. PubMed ID: 5780550
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of imipramine inhibition of platelet 5-hydroxytryptamine transport.
Talvenheimo J; Nelson PJ; Rudnick G
J Biol Chem; 1979 Jun; 254(11):4631-5. PubMed ID: 438209
[TBL] [Abstract][Full Text] [Related]
19. Uptake, release, and subcellular localization of 1-methyl-4-phenylpyridinium in blood platelets.
Cesura AM; Ritter A; Picotti GB; Da Prada M
J Neurochem; 1987 Jul; 49(1):138-45. PubMed ID: 3495635
[TBL] [Abstract][Full Text] [Related]
20. Isolated 5-hydroxytryptamine organelles of rabbit blood platelets: physiological properties and drug-induced changes.
Da Prada M; Pletscher A
Br J Pharmacol; 1968 Nov; 34(3):591-7. PubMed ID: 5726788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
